Atlas Trials

Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers

Clinical trial NCT04281758 · COMPLETED

Trial details

NCT number
NCT04281758
Sponsor
PepsiCo Global R&D
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Plasma Caffeine Concentration
Start date
2020-07-20
Primary completion
2020-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.